En poursuivant votre navigation sur ce site, vous acceptez l'utilisation d'un simple cookie d'identification. Aucune autre exploitation n'est faite de ce cookie. OK
0

Validation of a commercially available indirect ELISA using a nucleocapside recombinant protein for detection of Schmallenberg virus antibodies.

Favoris Signaler une erreur
Article
H

Bréard, Emmanuel ; Lara, E. ; Comtet, L. ; Viarouge, Cyril ; Doceul, V. ; Desprat, Alexandra ; Vitour, D. ; Pozzi, N. ; Cay, A.B. ; De Regge, N. ; Pourquier, P. ; Schirrmeier, H. ; Hoffmann, B. ; Beer, M. ; Sailleau, Corinne ; Zientara, Stéphan

PLOS ONE

Unite Mixte de Recherche Virologie 1161, Agence Nationale de Securite Sanitaire, 23 Ave du Generale de Gaulle, Maisons-Alfort 94076, France.

2013

Article

Abstract: A newly developed Enzym Like Immuno Sorbant Assay (ELISA) based on the recombinant nucleocapsid protein (N) of Schmallenberg virus (SBV) was evaluated and validated for the detection of SBV-specific IgG antibodies in ruminant sera by three European Reference Laboratories. Validation data sets derived from sheep, goat and bovine sera collected in France and Germany (n=1515) in 2011 and 2012 were categorized according to the results of a virus neutralization test (VNT) or an indirect immuno-flurorescence assay (IFA). The specificity was evaluated with 1364 sera from sheep, goat and bovine collected in France and Belgium before 2009. Overall agreement between VNT and ELISA was 98.9% and 98.3% between VNT and IFA, indicating a very good concordance between the different techniques. Although cross-reactions with other Orthobunyavirus from the Simbu serogroup viruses might occur, it is a highly sensitive, specific and robust ELISA-test validated to detect anti-SBV antibodies. This test can be applied for SBV sero-diagnostics and disease-surveillance studies in ruminant species in Europe.
Favoris Signaler une erreur